STOCK TITAN

McKesson Stock Price, News & Analysis

MCK NYSE

Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.

McKesson Corporation (MCK) delivers vital healthcare supply chain solutions through pharmaceutical distribution, medical-surgical product management, and technology services. This page provides investors and industry observers with direct access to McKesson's official news updates and market-moving developments.

Track earnings announcements, strategic partnerships, and regulatory filings alongside operational milestones shaping McKesson's role in healthcare logistics. Our curated feed consolidates press releases and verified news to help stakeholders monitor the company's performance in pharmaceutical wholesale and healthcare IT innovation.

Discover updates on McKesson's supply chain optimization initiatives, technology platform enhancements, and collaborations with hospitals, pharmacies, and manufacturers. Bookmark this page for efficient monitoring of developments impacting one of North America's leading healthcare distribution networks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.47%
Tags
-
Rhea-AI Summary

The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on July 3, 2023, to stockholders recorded as of June 1, 2023. McKesson, a leader in healthcare services, focuses on improving health outcomes by partnering with various sectors including biopharma companies, care providers, and pharmacies. The company aims to enhance accessibility and affordability in healthcare, impacting numerous areas within the industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
dividends
Rhea-AI Summary

McKesson Corporation (NYSE: MCK) is set to release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. A live webcast of the earnings conference call will be held at 4:30 PM Eastern Time to discuss the financial outcomes. Investors can access the webcast on McKesson’s Investor Relations website, where the earnings release and supporting materials will also be available. McKesson is a leader in healthcare services, dedicated to improving health outcomes and partnering with various stakeholders to enhance the accessibility and affordability of quality care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
-
Rhea-AI Summary

McKesson Medical-Surgical Government Solutions LLC, based in Richmond, Va., has been awarded a five-year contract by the U.S. Department of Veterans Affairs for Federal Supply Schedule 65 II A. This contract allows greater access to McKesson’s medical supplies, including respiratory accessories and surgical instruments. According to Deborah Haywood, VP of Government Solutions, this milestone enhances McKesson’s ability to positively impact patient outcomes and create cost efficiencies in healthcare. The inclusion on the FSS facilitates expansion in providing high-quality medical supplies to federal customers, especially for veterans and the military community.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
none
-
Rhea-AI Summary

McKesson Corporation (NYSE: MCK) has announced its financial results for the third quarter of fiscal 2023. The detailed results are accessible on McKesson's Investor Relations website. A live webcast to discuss these results is scheduled for February 1st at 4:30 PM ET. McKesson is recognized as a leader in healthcare services, focusing on enhancing health outcomes through partnerships with various stakeholders, including biopharma companies and care providers. For additional insights about the company's impact in healthcare, visit McKesson.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.21%
Tags
Rhea-AI Summary

The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on April 3, 2023, to stockholders of record as of March 1, 2023. McKesson is a leader in diversified healthcare services, committed to enhancing health outcomes by collaborating with various stakeholders in the healthcare ecosystem.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
dividends
-
Rhea-AI Summary

McKesson Corporation (NYSE: MCK) will announce its third-quarter fiscal 2023 financial results on February 1, 2023, after market close. Investors can join a live webcast at 4:30 PM Eastern Time to discuss the results. The webcast will be accessible through McKesson's Investor Relations website, where the earnings release and financial documents will also be available. McKesson is a leader in healthcare services, partnering with various stakeholders to enhance healthcare access and affordability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
-
Rhea-AI Summary

McKesson Corporation (NYSE: MCK) has announced its fiscal 2023 second-quarter financial results, which are available on their Investor Relations website. A live webcast for investors will be held on November 1 at 4:30 PM ET to discuss these results. McKesson, a leader in healthcare services, is committed to enhancing health outcomes for patients by collaborating with various healthcare stakeholders. For more information on McKesson's financials and upcoming events, please visit their Investor Relations site.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
Rhea-AI Summary

The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share. This dividend is set to be paid on January 3, 2023, to stockholders of record as of December 1, 2022. McKesson, a leader in healthcare services, aims to improve health outcomes by collaborating with various stakeholders in the healthcare ecosystem.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
dividends

FAQ

What is the current stock price of McKesson (MCK)?

The current stock price of McKesson (MCK) is $698.31 as of September 19, 2025.

What is the market cap of McKesson (MCK)?

The market cap of McKesson (MCK) is approximately 85.8B.
McKesson

NYSE:MCK

MCK Rankings

MCK Stock Data

85.84B
124.34M
0.03%
90.66%
1.51%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
IRVING